本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ocular Therapeutix

8.86
+0.07000.80%
盘后8.950.0900+1.02%19:31 EDT
成交量:284.62万
成交额:2,528.15万
市值:19.29亿
市盈率:-6.24
高:9.07
开:8.73
低:8.70
收:8.79
52周最高:16.44
52周最低:6.23
股本:2.18亿
流通股本:1.91亿
量比:0.72
换手率:1.49%
股息:- -
股息率:- -
每股收益(TTM):-1.4203
每股收益(LYR):-1.4203
净资产收益率:-54.85%
总资产收益率:-26.66%
市净率:2.95
市盈率(LYR):-6.24

数据加载中...

2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/07/22

重要事件披露

8-K - Current report
2021/06/22

重要事件披露

8-K - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/05/05

重要事件披露

8-K - Current report
2021/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/29

重要事件披露

8-K - Current report
2021/04/27

重要事件披露

8-K - Current report
2021/03/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans